María Del Mar Noblejas-López

8PUBLICATIONS
21CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 25, 2026
Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

|Oct 28, 2023
TACkling Cancer by Targeting Selective Protein Degradation.

María Del Mar Noblejas-López, David Tébar-García, Raquel López-Rosa

|Sep 23, 2022
Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers.

Alberto Juan, María Del Mar Noblejas-López, Iván Bravo

|May 28, 2022
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.

María Del Mar Noblejas-López, Lucía Gandullo-Sánchez, Eva M Galán-Moya

|Aug 27, 2021
Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer.

María Del Mar Noblejas-López, Igor López-Cade, Jesús Fuentes-Antrás

|Apr 30, 2021
Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.

María Del Mar Noblejas-López, Mariona Baliu-Piqué, Cristina Nieto-Jiménez

Pageof 2

Frequent Collaborators

3 joint publications

Iván Bravo

3 joint publications

Eva María Galán-Moya

3 joint publications

Alberto Ocaña

2 joint publications

Alberto Juan